MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
about
Hepatobiliary MR imaging with gadolinium-based contrast agentsRadiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisContrast Enhanced MRI in the Diagnosis of HCCAdvances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaDiagnostic and therapeutic management of hepatocellular carcinomaAssociation between hepatitis C and hepatocellular carcinomaRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRIHow I do it: Cone-beam CT during transarterial chemoembolization for liver cancerImaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoringNon-invasive diagnosis of abdomino-pelvic masses: role of multimodality imagingAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models.DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.Natural history of liver imaging reporting and data system category 4 nodules in MRI.Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5.Diffusion weighted imaging in the liver.Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibilityResection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcomeThe utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images.Primary clear cell carcinoma in the liver: CT and MRI findings.Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging featuresThe growing epidemic of hepatocellular carcinoma.Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liverHepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications.The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review.Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.Grading of small hepatocellular carcinomas (≤2 cm): correlation between histology, T2 and diffusion-weighted imagingOptimising the scan delay for arterial phase imaging of the liver using the bolus tracking technique.MRI of hepatocellular carcinoma: an update of current practices.Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination.Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT.Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes
P2860
Q24631773-55180631-15B9-4BE9-953B-5954D5B8F848Q26738533-BD2E4DF6-B474-4F85-86DF-890C30D68400Q26768472-CD124D21-5F78-424D-86E4-4A053AEBA783Q26772334-18B5727D-CBA3-44B5-8337-F35B9E787E14Q26999043-DE5CDF26-9580-43B6-9BDD-77179A1D7EF3Q27491295-F3DD4CEA-F5A7-4E32-B72E-F60BE653C02CQ28075361-EE1683A9-B967-4C30-A82B-EB4C520444A4Q28087066-79E58E46-10F3-43A5-B0B1-D585FE1C0F47Q30436747-CEBE8D0E-05C9-4B74-A99E-D39C32A9A1DCQ30455378-99400A50-9CA5-434D-A9F3-4F3FAAD97243Q30479629-BA3EBD0C-04C8-4248-B62F-A308712DA699Q30977219-89748120-FF0E-4196-A811-F9172C49283DQ31030824-12E60BC2-7715-4984-9631-1C49E197EE32Q31090559-7FA2B3C9-DBD9-47B1-8164-7654EA9F4FFCQ31154548-9CFD5377-997F-4099-BB04-BBCB7E3EE441Q33547861-87C55BAE-E0E7-431F-A3B0-C0E6520B3C7CQ33617869-E4B51A42-3BA1-4B6F-9378-3A34B94BC35EQ33648955-8DC95456-5095-41BC-B5F3-C9505304FA93Q33759248-4FA4920F-D88A-43A1-B71C-9C57FF8D1F42Q34207805-28EAA64E-A99D-4941-9CB3-EBDE7C98ECAEQ34331579-A839C9EA-2CB6-4A72-985F-BE782ECE900EQ34635076-2BEA7C0B-8944-47AC-874F-F42B19511E2FQ34681046-87B22946-F2A2-4B45-AF6D-EF00BAC3239CQ34681076-682089AD-FC26-493D-99C1-2AD22A9A74EBQ34682228-4CE07BE5-B00C-48E5-A593-3B3343B98D9BQ35014615-6DFC66F5-C7E2-4DDD-B461-71EB28020CB7Q35112154-6AD63623-0B30-488E-80FB-AF9519C5B83BQ35124054-36C93CF2-281C-47AF-BA15-E1BE457CA292Q35154056-82879527-CE5D-49FD-9614-24DECB4FFE82Q35207736-6856E07D-1A11-4AC0-851A-67ADC48EEE53Q35626757-7353294F-7298-41A5-95B4-51279120354EQ35676681-8BBEAA7C-0D65-41AA-8E7D-B15AE77FBD52Q35691865-74C74A73-C15B-417C-9343-DBC40CC1EE32Q35721200-842D30C3-9AA3-431E-8AB8-2B764FF25BC0Q35852266-DAC83A0F-97C6-465C-B8DC-367E14CA7544Q36214807-E37B3DD1-4F79-4687-8998-7337F62D2D9CQ36324508-AFF5731C-2FA3-45BB-B094-F1C504F9DBB0Q36325824-010BF845-4D20-4C61-A3A1-1BD36F1124B2Q36326113-EE20A752-E6A0-4019-B5EF-BBACCD57C45CQ36512761-ABD16768-2D46-4DE6-ABBE-5AFA5F290CA1
P2860
MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MR Imaging of hepatocellular c ...... challenges and controversies.
@en
MR Imaging of hepatocellular c ...... challenges and controversies.
@nl
type
label
MR Imaging of hepatocellular c ...... challenges and controversies.
@en
MR Imaging of hepatocellular c ...... challenges and controversies.
@nl
prefLabel
MR Imaging of hepatocellular c ...... challenges and controversies.
@en
MR Imaging of hepatocellular c ...... challenges and controversies.
@nl
P2093
P1433
P1476
MR Imaging of hepatocellular c ...... challenges and controversies.
@en
P2093
Hero K Hussain
Jonathon M Willatt
Jorge A Marrero
Saroja Adusumilli
P304
P356
10.1148/RADIOL.2472061331
P407
P577
2008-05-01T00:00:00Z